Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative associations of the TyG index and HOMA2-IR with 6-month outcomes after moderate-to-severe traumatic brain injury: a single-center retrospective cohort study.

Frontiers in molecular neuroscience·2026
Same author

A machine learning model for diabetic retinopathy risk stratification using routine blood and urine parameters: insights into kidney-eye crosstalk.

Frontiers in endocrinology·2026
Same author

Ablation of idiopathic fascicular ventricular tachycardia in a patient with congenitally corrected transposition of the great arteries: A case report.

HeartRhythm case reports·2026
Same author

DMSO Protects Against Radiation-Induced Ovarian Injury by Preserving Mitochondrial Function and Alleviating DNA Damage.

Dose-response : a publication of International Hormesis Society·2026
Same author

Hydrogel Electronic Skin Synergistically Enhanced by Multibond Crosslinking and a Negative Poisson's Ratio Structure for Human Respiration Monitoring.

ACS sensors·2026
Same author

Tectorigenin Protects Irradiation-Induced Injury of HUVECs by Inhibiting Mitophagy Through PINK1/Parkin Pathway.

Frontiers in bioscience (Landmark edition)·2026

Related Experiment Video

Updated: Feb 24, 2026

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

4.3K

CARTs for Solid Tumors: Feasible or Infeasible?

Wei Li, Xiujun Song, Yanwen Jin

    Oncology Research and Treatment
    |August 17, 2017
    PubMed
    Summary

    Chimeric antigen receptor (CAR)-T cell therapy shows promise for treating B-cell cancers. This review explores CAR design principles and clinical studies for solid tumors, highlighting challenges and future directions.

    Keywords:
    Chimeric antigen receptorImmunotherapySolid tumorT cell

    More Related Videos

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
    06:08

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

    Published on: February 10, 2023

    1.9K
    Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
    10:38

    Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

    Published on: December 16, 2022

    2.8K

    Related Experiment Videos

    Last Updated: Feb 24, 2026

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
    05:22

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

    Published on: February 24, 2023

    4.3K
    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
    06:08

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

    Published on: February 10, 2023

    1.9K
    Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
    10:38

    Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

    Published on: December 16, 2022

    2.8K

    Area of Science:

    • Immunology
    • Oncology
    • Biotechnology

    Background:

    • Chimeric antigen receptor (CAR)-T cell therapy is a novel cancer treatment approach.
    • CAR-T cells combine antibody specificity with T cell activation for targeted cancer therapy.
    • Exciting results exist for B-cell malignancies, but solid tumor applications are less explored.

    Purpose of the Study:

    • To review the fundamental principles of CAR design.
    • To discuss current clinical studies involving CAR-T cells for solid tumors.
    • To highlight the challenges and potential of CAR-T cell therapy in solid tumors.

    Main Methods:

    • Review of preclinical and clinical trial data on CAR-T cells.
    • Analysis of different CAR configurations (antigens, binding domains, signal domains).
    • Focus on studies investigating CAR-T cells in solid tumor models and patients.

    Main Results:

    • CAR-T cell therapy has shown significant success in hematologic malignancies.
    • Variability in CAR design components across studies complicates direct comparisons.
    • Limited but emerging clinical data exists for CAR-T cells targeting solid tumors.

    Conclusions:

    • CAR-T cell therapy holds potential for solid tumors, but challenges remain.
    • Optimizing CAR design and overcoming the tumor microenvironment are crucial for efficacy.
    • Further research and clinical trials are needed to advance CAR-T cell therapy for solid tumors.